SPARC can regulate melanoma cell transition to an aggressive mesenchymal phenotype (that implies Rac1-GDP localization at the cytoplasm) by inducing the shift from E- to N-cadherin expression [6, 50]. The gene discussed is SPARC; the disease is melanoma.